2022 Insights on Drug Delivery Infusion Devices - Technological Advancements Such as the Development of Devices With Needlestick Prevention Features Are Driving Growth - ResearchAndMarkets.com | Business | thefacts.com

2022-08-27 00:23:48 By : Mr. Daniel Lin

Partly cloudy skies early followed by scattered thunderstorms overnight. Low 76F. Winds SSW at 5 to 10 mph. Chance of rain 40%..

Partly cloudy skies early followed by scattered thunderstorms overnight. Low 76F. Winds SSW at 5 to 10 mph. Chance of rain 40%.

DUBLIN--(BUSINESS WIRE)--Aug 25, 2022--

The "Drug Delivery: Infusion Devices" newsletter has been added to ResearchAndMarkets.com's offering.

In 2021, global sales of infusion pumps and associated disposables were estimated at nearly $4.4bn, with volumetric and enteral pumps accounting for two-thirds of the market.

Market drivers include technological advancements such as the development of devices with needlestick prevention features and dose error reduction software, the expanding use of infusion pumps in home and alternate healthcare settings, the aging of the population and associated increase of chronic conditions requiring infusion drug delivery, and a significant disposables aftermarket.

Market limiters include constrained healthcare spending in some countries due to slowed economic growth and legislative uncertainty in the healthcare marketplace, and, in the short term, a decline back to pre-pandemic levels of demand for infusion pumps following a significant COVID-19-related surge in 2020 and into 2021.

This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global markets for infusion-based drug delivery devices including volumetric, syringe, ambulatory, disposable, implantable, and enteral pumps and accessories. Countries covered by this report include the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and the Rest of World. The forecast range for this report is 2021-26.

For more information about this newsletter visit https://www.researchandmarkets.com/r/v28rn2

View source version on businesswire.com:https://www.businesswire.com/news/home/20220825005553/en/

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

INDUSTRY KEYWORD: PHARMACEUTICAL HEALTH MEDICAL DEVICES

http://www.businesswire.com/news/home/20220825005553/en

Your entry has been submitted.

There was a problem reporting this.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language. PLEASE TURN OFF YOUR CAPS LOCK. Don't Threaten. Threats of harming another person will not be tolerated. Be Truthful. Don't knowingly lie about anyone or anything. Be Nice. No racism, sexism or any sort of -ism that is degrading to another person. Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts. Share with Us. We'd love to hear eyewitness accounts, the history behind an article.

Success! An email has been sent to with a link to confirm list signup.

Error! There was an error processing your request.

Get a list of the day’s obituaries, delivered to your inbox every day.

Would you like to receive our daily headlines?  Signup today!

Receive email alerts anytime there is breaking news or a severe weather alert.

Get a list of the day’s obituaries, delivered to your inbox every day.

Would you like to receive our daily headlines?  Signup today!

Your account has been registered, and you are now logged in.

Check your email for details.

Invalid password or account does not exist

Submitting this form below will send a message to your email with a link to change your password.

An email message containing instructions on how to reset your password has been sent to the e-mail address listed on your account.

Your purchase was successful, and you are now logged in.

A receipt was sent to your email.